{"id":995003,"date":"2026-08-13T12:41:25","date_gmt":"2026-08-13T16:41:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-october-5-2026-in-datavault-ai-inc-lawsuit-dvlt\/"},"modified":"2026-08-13T12:41:25","modified_gmt":"2026-08-13T16:41:25","slug":"suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-october-5-2026-in-datavault-ai-inc-lawsuit-dvlt","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-october-5-2026-in-datavault-ai-inc-lawsuit-dvlt\/","title":{"rendered":"SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Datavault AI Inc. Lawsuit – DVLT"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n Time-Sensitive: Allegations Focus on Undisclosed Information Concerning Company Leadership<\/i>\n <\/p>\n

\n NEW YORK<\/span>, Aug. 13, 2026<\/span> \/PRNewswire\/ — SueWallSt alerts investors in Datavault AI Inc. (NASDAQ: DVLT) of a pending securities class action on behalf of purchasers of DVLT securities between September 4, 2024 and October 30, 2025. Check if you might be eligible to recover your investment losses<\/a>. You may also contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com<\/a>\u00a0or (888) SueWallSt.<\/p>\n

\n

\n \"SueWallSt.com\"\n <\/p>\n<\/p><\/div>\n

DVLT shares fell $0.49 per share, or 19.44%, to close at $2.03 on October 31, 2025. The Court has set October 5, 2026 as the deadline to apply for lead plaintiff appointment.<\/p>\n

\n “Investors deserve transparency about material risks that could affect their investments. The complaint asserts that shareholders were never told about a senior officer’s prior SEC charges or the Company’s alleged<\/span> patent-level ties to an individual with a felony conviction for false statements.”<\/i>\u00a0— Joseph E. Levi, Esq.<\/p>\n

\n What Management Allegedly<\/span> Omitted About Leadership Background<\/b>\n <\/p>\n

The lawsuit asserts that when the Company announced its incoming chief executive in September 2024, management touted an “exceptional track record of successfully commercializing IP for five companies over 30 years” while omitting that the same individual had previously faced SEC charges for making false statements as an officer of a health sciences issuer. Those charges were resolved, as alleged<\/span>, through a $40,000 fine and a three-year ban from participating in penny stock offerings. The action claims the Company’s website also omitted that prior tenure entirely.<\/p>\n

\n
\n Alleged<\/span> Undisclosed Affiliations in the Patent Portfolio<\/b>\n <\/p>\n

As alleged<\/span>, an individual listed as a co-inventor alongside Company leadership on multiple acquired patents had previously pleaded guilty to making false statements in connection with a pump and dump scheme. According to the complaint, Datavault failed to disclose this affiliation to investors, and the later disclosure of the information revealed reputational risks that were not reflected in the Company’s stock price.<\/p>\n

\n Background Disclosure Concerns in Emerging-Technology Issuers<\/b>\n <\/p>\n